HaloPlex Cancer Research Panel by Agilent Technologies
Manufacturer Agilent Technologies
The HaloPlex Cancer Research Panel enables fast, simple, and efficient analysis of genomic regions of interest for cancer research for a large number of sample types, including FFPE.
HaloPlex Cancer is uniquely suited to high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage.Unlike competitive technologies, HaloPlex c... Read more
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
Related Products
HaloPlex Cancer Research Panel
The HaloPlex Cancer Research Panel enables fast, simple, and efficient analysis of genomic regions of interest for cancer research for a large number of sample types, including FFPE.
HaloPlex Cancer is uniquely suited to high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage.
Unlike competitive technologies, HaloPlex covers each base with several amplicons, and smaller fragments function as a backup for longer fragments that may fail. This allows for high sequencing target coverage even in highly degraded FFPE samples. FFPE also commonly produces small changes in single bases, cytosine to thymine, in DNA sequences.
HaloPlex Cancer Research Panel Features:
- 47 genes targeting COSMIC mutations
- Multiplex 96 samples on 1 MiSeq run
- Compatible with Ion Torrent & Illumina Desktop Sequencers
- Analyze samples with SureCall
- Easily customizable in SureDesign
Product Overview
